{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T11:58:18Z","timestamp":1768478298713,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.imlet.2015.08.001","type":"journal-article","created":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T00:54:28Z","timestamp":1438908868000},"page":"87-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Interleukin-37 expression is decreased in Beh\u00e7et's disease and is associated with inflammation"],"prefix":"10.1016","volume":"167","author":[{"given":"Eya","family":"Bouali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wajih","family":"Kaabachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Hamzaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamel","family":"Hamzaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.imlet.2015.08.001_bib0005","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.4049\/jimmunol.1202677","article-title":"Role of IL-22- and TNF-\u03b1-producing Th22 cells in uveitis patients with Behcet's disease","volume":"190","author":"Sugita","year":"2013","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.imlet.2015.08.001_bib0010","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.autrev.2011.12.005","article-title":"Cytokines and Behcet's disease","volume":"11","author":"Zhou","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.imlet.2015.08.001_bib0015","doi-asserted-by":"crossref","first-page":"CR227","DOI":"10.12659\/MSM.881720","article-title":"Expression of Th-17 and ROR\u03b3t mRNA in Beh\u00e7et's disease","volume":"17","author":"Hamzaoui","year":"2011","journal-title":"Med. Sci. Monit."},{"issue":"1\u20132","key":"10.1016\/j.imlet.2015.08.001_bib0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jneuroim.2011.01.012","article-title":"RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Beh\u00e7et's disease","volume":"233","author":"Hamzaoui","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.imlet.2015.08.001_bib0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/030097402320318387","article-title":"Cytokine profile in Beh\u00e7et's disease patients. Relationship with disease activity","volume":"31","author":"Hamzaoui","year":"2002","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.imlet.2015.08.001_bib0030","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.4049\/jimmunol.177.9.6415","article-title":"Characterization of the divergent wound healing responses occurring in the pathergy reaction and normal healthy volunteers","volume":"177","author":"Melikoglu","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2015.08.001_bib0035","article-title":"Possible association of proinflammatory cytokines including IL1\u03b2 and TNF\u03b1 with enhanced Th17 cell differentiation in patients with Behcet's disease","author":"Shimizu","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.imlet.2015.08.001_bib0040","first-page":"S1471","article-title":"Deciphering the crosstalk among IL-1 and IL-10 family cytokines in intestinal immunity","author":"Manzanillo","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.imlet.2015.08.001_bib0045","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1006\/geno.2000.6184","article-title":"Identification and gene organization of three novel members of the IL-1 family on human chromosome 2","volume":"66","author":"Busfield","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/j.imlet.2015.08.001_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/cyto.2000.0799","article-title":"IL-1H, an interleukin-1-related protein that binds IL-18 receptor\/IL-1Rrp","volume":"13","author":"Pan","year":"2001","journal-title":"Cytokine"},{"key":"10.1016\/j.imlet.2015.08.001_bib0055","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.1944","article-title":"IL-37 is a fundamental inhibitor of innate immunity","volume":"11","author":"Nold","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2015.08.001_bib0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1479-5876-12-69","article-title":"IL-37 inhibits the production of inflammatory cytokines in peripheral bloodmononuclear cells of patients with systemic lupus erythematosus, its correlation with disease activity","volume":"12","author":"Liang","year":"2014","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.imlet.2015.08.001_bib0065","doi-asserted-by":"crossref","first-page":"e95346","DOI":"10.1371\/journal.pone.0095346","article-title":"Plasma levels of IL-37 and correlation with TNF-\u03b1, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2015.08.001_bib0070","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10875-012-9791-z","article-title":"Glucocorticoid regulates interleukin-3 in systemic lupus erythematosus","volume":"33","author":"Song","year":"2013","journal-title":"J. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2015.08.001_bib0075","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cyto.2013.06.174","article-title":"IL-37 suppresses contact hypersensitivity by inducing tolerogenic dendritic cells","volume":"63","author":"Luo","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.imlet.2015.08.001_bib0080","first-page":"1078","article-title":"International Study Group for Behcet's disease. Criteria for diagnosis of Behcet's disease","volume":"335","author":"International Study Group for Behcet's Disease","year":"1990","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.imlet.2015.08.001_bib0085","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.autrev.2014.12.009","article-title":"IFN-\u03b1 induces IL-10 production and tilt the balance between Th1 and Th17 in Beh\u00e7et disease","volume":"14","author":"Touzot","year":"2015","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.imlet.2015.08.001_bib0090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.imlet.2014.01.001","article-title":"Increased IL-23 receptor, TNF-\u03b1 and IL-6 expression in individuals with the IL23R-IL12RB2 locus polymorphism","volume":"160","author":"Cavu\u015f","year":"2014","journal-title":"Immunol. Lett."},{"issue":"4","key":"10.1016\/j.imlet.2015.08.001_bib0095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/jir.2014.0042","article-title":"Decreased interleukin-37 expression in Vogt-Koyanagi-Harada disease and upregulation following immunosuppressive treatment","volume":"35","author":"Ye","year":"2015","journal-title":"J. Interferon Cytokine Res."},{"issue":"3","key":"10.1016\/j.imlet.2015.08.001_bib0100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1684\/ecn.2011.0288","article-title":"IL-37, a new anti-inflammatory cytokine of the IL-1 family","volume":"22","author":"Boraschi","year":"2011","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.imlet.2015.08.001_bib0105","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2174\/1566524014666140414210831","article-title":"A possible role for interleukin 37 in the pathogenesis of Behcet's disease","volume":"14","author":"Ye","year":"2014","journal-title":"Curr. Mol. Med."},{"issue":"3 Suppl. 72","key":"10.1016\/j.imlet.2015.08.001_bib0110","first-page":"S80","article-title":"Beh\u00e7et's syndrome: a critical digest of the recent literature","volume":"30","author":"Hatemi","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"issue":"4 Suppl. 45","key":"10.1016\/j.imlet.2015.08.001_bib0115","first-page":"S34","article-title":"Dendritic cell subsets and type I interferon system in Beh\u00e7et's disease: does functional abnormality in plasmacytoid dendritic cells contribute to Th1 polarization?","volume":"25","author":"Pay","year":"2007","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.imlet.2015.08.001_bib0120","unstructured":"Wu W., Luo Y., Wang W, Yu G, Shen Y, Sun Z, et al. Interleukin-37 inhibits the activation of mouse dendritic cells induced by lipopolysaccharides]. Xi Bao Yu Fen ZiMian Yi XueZaZhi.(2015); 31(4):433-6."},{"issue":"11","key":"10.1016\/j.imlet.2015.08.001_bib0125","doi-asserted-by":"crossref","first-page":"e1004462","DOI":"10.1371\/journal.ppat.1004462","article-title":"IL-37 inhibits inflammasome activation and disease severity in murine aspergillosis","volume":"10","author":"Moretti","year":"2014","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.imlet.2015.08.001_bib0130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1586\/eop.12.30","article-title":"Immunological responses in patients with Beh\u00e7et's disease: advances in understanding","volume":"7","author":"Hamzaoui","year":"2012","journal-title":"Expert Rev. Ophtalmol."},{"key":"10.1016\/j.imlet.2015.08.001_bib0135","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGFb in the context of an inflammatory cytokinemilieu supports de novo differentiation ofIL-17-producing T cells","volume":"24","author":"Velhoen","year":"2006","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.imlet.2015.08.001_bib0140","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.4049\/jimmunol.1401810","article-title":"IL-37 alleviates rheumatoid arthritis by suppressing IL-17 and IL-17-triggering cytokine production and limiting Th17 cell proliferation","volume":"194","author":"Ye","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2015.08.001_bib0145","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1042\/BJ20040217","article-title":"Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide","volume":"381","author":"Bufler","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.imlet.2015.08.001_bib0150","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1073\/pnas.1424626112","article-title":"Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptorIL-1R8","author":"Li","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.imlet.2015.08.001_bib0155","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1440-1746.2012.07187.x","article-title":"Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells","volume":"27","author":"Sakai","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.imlet.2015.08.001_bib0160","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.4049\/jimmunol.1300047","article-title":"IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production","volume":"192","author":"Teng","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2015.08.001_bib0165","first-page":"762","article-title":"Protective host defenseagainstdisseminatedcandidiasisisimpaired in miceexpressing human interleukin-37","volume":"5","author":"van de Veerdonk","year":"2014","journal-title":"Front. Microbiol."},{"issue":"4 Suppl. 84","key":"10.1016\/j.imlet.2015.08.001_bib0170","first-page":"S149","article-title":"Anti-cytokine biologic treatment beyond anti-TNF in Beh\u00e7et's disease","volume":"32","author":"Arida","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"issue":"12","key":"10.1016\/j.imlet.2015.08.001_bib0175","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/rheumatology\/keu266","article-title":"Anti-TNF-\u00ed therapy in patients with refractoryuveitis due to Beh\u00e1et's disease: a 1-year follow-up study of 124 patients","volume":"53","author":"Calvo-R\u00edo","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.imlet.2015.08.001_bib0180","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.semarthrit.2014.08.004","article-title":"Tocilizumab for severerefractoryneuro-Beh\u00e7et: three cases IL-6 blockade in neuro-Beh\u00e7et","volume":"44","author":"Addimanda","year":"2015","journal-title":"Semin. Arthritis Rheum."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247815300158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247815300158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T23:24:27Z","timestamp":1599434667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247815300158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0165247815300158"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2015.08.001","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-37 expression is decreased in Beh\u00e7et's disease and is associated with inflammation","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2015.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}